The DryNeb dry powder nebulizer is a patented technology that can deliver drugs to the lower respiratory tract with much higher efficiency than current state of the art dry powder inhalers. DryNeb can deliver high dose, pure active ingredient, with rapid targeted delivery, and is being developed as a platform technology. Performance is unmatched by any known commercial or in-development dry powder inhaler and clearly differentiates the technology. Our technology has several key technological innovations compared to standard dry powder inhalers in generating highly efficient drug aerosols and delivering them effectively to the lower respiratory tract, independent of the patient’s lung capacity. DryNeb disperses the powder independently from the patient’s inhalation force, ensuring reproducible delivery no matter the lung function of the patient, and it is designed to emit powder from the device only when a patient inhales, thus no coordination is required.